HKD 2.8
(-0.71%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 322.34 Million CNY | 381.08% |
2022 | 87.84 Million CNY | -353.81% |
2021 | 42.1 Million CNY | -79.7% |
2020 | 207.43 Million CNY | 79.46% |
2019 | -32.34 Million CNY | 2.83% |
2018 | 112.4 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q4 | 37.23 Million CNY | -39.61% |
2023 Q2 | 61.64 Million CNY | 134.66% |
2023 FY | - CNY | 381.08% |
2022 Q2 | 60.44 Million CNY | 151.39% |
2022 FY | - CNY | -353.81% |
2022 Q4 | -177.84 Million CNY | -394.21% |
2021 Q2 | 159.73 Million CNY | 58.62% |
2021 FY | - CNY | -79.7% |
2021 Q4 | -117.62 Million CNY | -173.64% |
2020 Q4 | 100.69 Million CNY | -5.66% |
2020 Q2 | 106.73 Million CNY | 0.0% |
2020 FY | - CNY | 79.46% |
2019 FY | - CNY | 2.83% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -368.2% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | -99.001% |
Human Health Holdings Limited | 104.06 Million HKD | -209.757% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | -10.353% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -141.257% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | -510.99% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | 829.438% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | 10.43% |
Town Health International Medical Group Limited | 53.5 Million HKD | -502.505% |
Medicskin Holdings Limited | 6.77 Million HKD | -4657.172% |
Hang Chi Holdings Limited | 81.58 Million HKD | -295.095% |